Yang WH - Search Results

1

Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).

Ballangrud AM, Yang WH, Charlton DE, McDevitt MR, Hamacher KA, Panageas KS, Ma D, Bander NH, Scheinberg DA, Sgouros G. Ballangrud AM, et al. Among authors: yang wh. Cancer Res. 2001 Mar 1;61(5):2008-14. Cancer Res. 2001. PMID: 11280760

2

Combination treatment with 17-N-allylamino-17-demethoxy geldanamycin and acute irradiation produces supra-additive growth suppression in human prostate carcinoma spheroids.

Enmon R, Yang WH, Ballangrud AM, Solit DB, Heller G, Rosen N, Scher HI, Sgouros G. Enmon R, et al. Among authors: yang wh. Cancer Res. 2003 Dec 1;63(23):8393-9. Cancer Res. 2003. PMID: 14679001

3

Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.

Ballangrud AM, Yang WH, Palm S, Enmon R, Borchardt PE, Pellegrini VA, McDevitt MR, Scheinberg DA, Sgouros G. Ballangrud AM, et al. Among authors: yang wh. Clin Cancer Res. 2004 Jul 1;10(13):4489-97. doi: 10.1158/1078-0432.CCR-03-0800. Clin Cancer Res. 2004. PMID: 15240541

4

Growth and characterization of LNCaP prostate cancer cell spheroids.

Ballangrud AM, Yang WH, Dnistrian A, Lampen NM, Sgouros G. Ballangrud AM, et al. Among authors: yang wh. Clin Cancer Res. 1999 Oct;5(10 Suppl):3171s-3176s. Clin Cancer Res. 1999. PMID: 10541360

5

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, Sgouros G, Ballangrud AM, Yang WH, Finn RD, Pellegrini V, Geerlings MW Jr, Lee M, Brechbiel MW, Bander NH, Cordon-Cardo C, Scheinberg DA. McDevitt MR, et al. Among authors: yang wh. Cancer Res. 2000 Nov 1;60(21):6095-100. Cancer Res. 2000. PMID: 11085533

6

Spheroids of prostate tumor cell lines.

Sgouros G, Yang WH, Enmon R. Sgouros G, et al. Among authors: yang wh. Methods Mol Med. 2003;81:79-88. doi: 10.1385/1-59259-372-0:79. Methods Mol Med. 2003. PMID: 12725116 No abstract available.

7

Binding and interstitial penetration of liposomes within avascular tumor spheroids.

Kostarelos K, Emfietzoglou D, Papakostas A, Yang WH, Ballangrud A, Sgouros G. Kostarelos K, et al. Among authors: yang wh. Int J Cancer. 2004 Nov 20;112(4):713-21. doi: 10.1002/ijc.20457. Int J Cancer. 2004. PMID: 15382056

8

Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody.

Emfietzoglou D, Kostarelos K, Papakostas A, Yang WH, Ballangrud A, Song H, Sgouros G. Emfietzoglou D, et al. Among authors: yang wh. J Nucl Med. 2005 Jan;46(1):89-97. J Nucl Med. 2005. PMID: 15632038 Free article.

9

Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids.

Kostarelos K, Emfietzoglou D, Papakostas A, Yang WH, Ballangrud AM, Sgouros G. Kostarelos K, et al. Among authors: yang wh. J Liposome Res. 2005;15(1-2):15-27. doi: 10.1081/lpr-64953. J Liposome Res. 2005. PMID: 16194925

10

[Comprehensive evaluation of resistance to Cd stress in mycorrhizal seedlings formed by different genotypes of Cenococcum geophilum and Pinus massoniana].

Zhang X, Yan TY, Zhang YH, Wu AL, Xie RZ, Zhang TX, Yang WH. Zhang X, et al. Among authors: yang wh. Ying Yong Sheng Tai Xue Bao. 2024 Oct;35(10):2677-2687. doi: 10.13287/j.1001-9332.202410.008. Ying Yong Sheng Tai Xue Bao. 2024. PMID: 39727114 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

763 results

Search Page

Filters